Tytuł pozycji:
Reply to Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women.
-
Tytuł:
-
Reply to Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women.
-
Autorzy:
-
Pérez-Castrillón JL; Internal Medicine Department, Hospital Universitario Río Hortega, Valladolid, Spain.; School of Medicine, Universidad de Valladolid, Valladolid, Spain.
Dueñas-Laita A; School of Medicine, Universidad de Valladolid, Valladolid, Spain.; Clinical Toxicology Unit, Hospital Universitario Río Hortega, Valladolid, Spain.
Gómez-Alonso C; Bone Metabolism Unit, Hospital Universitario Central de Asturias-Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
Bouillon R; Department of Chronic Diseases and Metabolism, Katholieke Universiteit (KU) Leuven, Leuven, Belgium.
Jódar E; Department of Endocrinology & Clinical Nutrition, Hospital Universitario Universitario Quironsalud Madrid, Madrid, Spain.; School of Health Sciences, Universidad Europea, Madrid, Spain.
Brandi ML; Dipartimento di Scienze Biomediche, Sperimentali e Cliniche 'Mario Serio', Università degli Studi di Firenze, Florence, Italy.
González-Macías J; Instituto de Investigación Marqués de Valdecilla - Instituto de Investigación Marqués de Valdecilla (IDIVAL), Santander, Spain.; School of Medicine, Universidad de Cantabria, Santander, Spain.
Quesada-Gómez JM; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.; Hospital Universitario Reina Sofía, Córdoba, Spain.
Olmos Martínez JM; School of Medicine, Universidad de Cantabria, Santander, Spain.; Internal Medicine Department, Hospital Universitario Marqués de Valdecilla-Instituto de Investigación Marqués de Valdecilla (IDIVAL), Santander, Spain.
Galarraga B; Rheumatology Department, Hospital Quirónsalud Bizkaia, Erandio, Spain.
Del Pino-Montes J; School of Medicine, Universidad de Salamanca, Salamanca, Spain.
Alhambra Expósito MR; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.; Endocrinology and Nutrition Unit, Hospital Universitario Reina Sofía, Córdoba, Spain.
Cereto Castro F; Internal Medicine Department, Hospital Quirón Barcelona, Barcelona, Spain.
Gallego López L; Hospital Universitario Virgen Macarena, Sevilla, Spain.
Hernández-Herrero G; R&D and Innovation Department, Faes Farma, Leioa, Spain.
Fernández-Hernando N; R&D and Innovation Department, Faes Farma, Leioa, Spain.
Arranz-Gutiérrez P; R&D and Innovation Department, Faes Farma, Leioa, Spain.
Chinchilla SP; R&D and Innovation Department, Faes Farma, Leioa, Spain.
-
Źródło:
-
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2022 Jul; Vol. 37 (7), pp. 1413-1415. Date of Electronic Publication: 2022 Jun 10.
-
Typ publikacji:
-
Letter; Comment
-
Język:
-
English
-
Imprint Name(s):
-
Publication: 2000- : Washington, DC : American Society for Bone and Mineral Research
Original Publication: New York : Mary Ann Liebert, Inc., c1986-
-
MeSH Terms:
-
Calcifediol*
Osteoporosis, Postmenopausal*
Cholecalciferol ; Dietary Supplements ; Female ; Humans ; Postmenopause ; Vitamin D
-
Substance Nomenclature:
-
1406-16-2 (Vitamin D)
1C6V77QF41 (Cholecalciferol)
P6YZ13C99Q (Calcifediol)
-
Entry Date(s):
-
Date Created: 20220524 Date Completed: 20220714 Latest Revision: 20220921
-
Update Code:
-
20240105
-
DOI:
-
10.1002/jbmr.4612
-
PMID:
-
35607257
-
Comment on: J Bone Miner Res. 2021 Oct;36(10):1967-1978. (PMID: 34101900)
Comment on: J Bone Miner Res. 2022 Jul;37(7):1411-1412. (PMID: 35451531)
